Possible association of dose rate and the development of late visual toxicity for patients with intracranial tumours treated with pencil beam scanned proton therapy

• Published in: Radiation oncology (London, England) England), 2024-06, Vol.19 (1), p.75-9, Article 75
• Main Authors: Meijers, Arturs, Daartz, Juliane, Knopf, Antje-Christin, van Heerden, Michelle, Bizzocchi, Nicola, Vazquez, Miriam Varela, Bachtiary, Barbara, Pica, Alessia, Shih, Helen A, Weber, Damien Charles
• Format: Article
• Language: English
• Subjects: Adult; Aged; Analysis; Brain Neoplasms - radiotherapy; Care and treatment; Diagnosis; Dose rate; Dose-Response Relationship, Radiation; Female; Humans; Intracranial tumors; Male; Middle Aged; Optic Nerve - radiation effects; Organs at Risk - radiation effects; Patient outcomes; Proton beam radiotherapy; Proton therapy; Proton Therapy - adverse effects; Proton Therapy - methods; Radiation induced neuropathy; Radiation Injuries - etiology; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted - methods; Toxicity testing; Visual toxicity
• ISSN: 1748-717X; 1748-717X
• DOI: 10.1186/s13014-024-02464-z

Rare but severe toxicities of the optic apparatus have been observed after treatment of intracranial tumours with proton therapy. Some adverse events have occurred at unusually low dose levels and are thus difficult to understand considering dose metrics only. When transitioning from double scattering to pencil beam scanning, little consideration was given to increased dose rates observed with the latter delivery paradigm. We explored if dose rate related metrics could provide additional predicting factors for the development of late visual toxicities. Radiation-induced intracranial visual pathway lesions were delineated on MRI for all index cases. Voxel-wise maximum dose rate (MDR) was calculated for 2 patients with observed optic nerve toxicities (CTCAE grade 3 and 4), and 6 similar control cases. Additionally, linear energy transfer (LET) related dose enhancing metrics were investigated. For the index cases, which developed toxicities at low dose levels (mean, 50 Gy ), some dose was delivered at higher instantaneous dose rates. While optic structures of non-toxicity cases were exposed to dose rates of up to 1 to 3.2 Gy /s, the pre-chiasmatic optic nerves of the 2 toxicity cases were exposed to dose rates above 3.7 Gy /s. LET-related metrics were not substantially different between the index and non-toxicity cases. Our observations reveal large variations in instantaneous dose rates experienced by different volumes within our patient cohort, even when considering the same indications and beam arrangement. High dose rate regions are spatially overlapping with the radiation induced toxicity areas in the follow up images. At this point, it is not feasible to establish causality between exposure to high dose rates and the development of late optic apparatus toxicities due to the low incidence of injury.